Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer

Hepato-Gastroenterology

Volumn 57, Issue 97, 2010, Pages 76-80

  Osada, Shinji ^a   Matsui, Satoshi ^a   Komori, Shuji ^a   Yamada, Junko ^a   Sanada, Yuichi ^a   Ikawa, Aiko ^a   Tanaka, Yoshihiro ^a   Tokuyama, Yasuharu ^a   Okumura, Naoki ^a   Nonaka, Kenichi ^a   Hosono, Yoshiki ^a   Takahashi, Takao ^a   Yamaguchi, Kazuya ^a   Yoshida, Kazuhiro ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

c Met; Colorectal cancer; Hepatocyte growth factor; Liver metastasis

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLINESTERASE; INDOCYANINE GREEN; LIGAND; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ACID PHOSPHATASE BLOOD LEVEL; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER RELAPSE; CANCER TISSUE; CHOLINESTERASE BLOOD LEVEL; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER FUNCTION; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM FACTOR; WESTERN BLOTTING;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MET; TRANSAMINASES; TREATMENT OUTCOME;

EID: 77952001165     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Lochan R, White SA, Manas DM: Liver resection for colorectal liver metastasis. Surg Oncol 2007; 16: 33-45.
3. Bengtsson G, Carlsson G, Hafstrom L, et al: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141: 586-589.
4. Bengmark S, Hafstrom L: The natural history of primary and secondary malignant tumors of the liver. II. The prognosis for patients with hepatic metastases from gastric carcinoma verified by laparotomy and postmortem examination. Digestion 1969; 2: 179-186.
5. Park M, Dean M, Cooper CS, et al: Mechanism of met oncogene activation. Cell 1986;45:895-904.
6. Bottaro DP, Rubin JS, Faletto DL, et al: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
7. Osada S, Kanematsu M, Imai H, et al: Evaluation of exrtracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma. J Am Coll Surg 2005; 201: 405-411.
8. Di Renzo MF, Olivero M, Giacomini A, et al: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-154.
9. Takeuchi H, Bilchik A, Saha S, et al: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 2003; 9: 1480-1488.
10. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997; 276: 60-66.
11. Osada S, Saji S, Kuno T: Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma. J Surg Oncol 2004; 85: 48-54.
12. Primrose JN: Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 2002; 50:1-5.
13. Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
14. Nordlinger B, Vaillant JC, Guiguet M, et al: Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12: 1491-1496.
15. Stangl R, Altendorf-Hofmann A, Charnley RM, et al: Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-1410.
16. Harun N, Nikfarjam M, Muralidharan V, et al: Liver regeneration stimulates tumor metastases. J Surg Res 2007; 138: 284-290.
17. Yamagami H, Moriyama M, Mtsumura H, et al: Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in c-viral chronic liver diseases. Cancer 2002; 95: 824-834.
18. Mizuguchi T, Katsuramaki T, Nobuta T, et al: Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg 2004; 28: 971-976.
19. Matsumoto K, Nakamura T: Hepatocyte growth factors: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol 1991; 6: 509-519.
20. Wu F, Wu, L, Zheng S, et al: The clinical value of hepatocyte growth factor and its receptor-c met for liver cancer patients with hepatectomy. Dig Liver Dis 2006; 38; 490-497.
21. Chijiiwa K, SaikiS, Tanaka M: Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy. Hepatogastroenterol 2002; 49: 467-471.
22. Sowa JP, Best J, Benko T, et al: Extent liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World J Gastroenterol 2008; 14: 7093-7100.
23. Osada S, Saji S: The clinical significance of monitoring alkaline phosphatase level to estimate postoperative liver failure after hepatectomy. Hepatogastroenterol 2004; 51: 1434-1438.
24. Monvoisin A, Neaud V, De Ledinghen V, et al: Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol 1999; 30; 511-518.
25. Junbo H, Li Q, Zaide W, Yunde H: Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In vivo 1999; 13; 177-180.
26. Matsumoto K, Nakashima T, Kramer RH: Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994; 269: 31807-31813.
27. Luo YQ, Wu MC, Cong WM: Gene expression of hepatocyte growth factor and its receptor in HCC and nontumor ous liver tissues. World J Gastroenterol 1999; 5:119-121.
28. Jiang W, Hiscox S, Matsumoto K, et al: Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999; 29: 209-248.
29. Fazekas K, Csuka O, Koves I, et al: Experimental and clinicopathologic studies on the function of the HGF. Clin Exp Metast 2000; 18; 639-649.
30. Herynk MH, Stoeltzing O, Reinmuth N, et al: Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 2003; 63: 2990-2996.
31. Resnick MB, Routhier J, Konkin T, et al: Epidermal growth factor receptor, c-Met, beta-catenin and p53 expression as prognostic indicator in stage II colon cancer: A tissue microarray study. Clin Cancer Res 2004; 10; 3069-3075.
32. Zeng ZS, Weiser MR, Kunts E, et al: c-Met gene amplification associated with advanced stage colorectal cancer and liver metastasis. Cancer Lett 2008; 365; 258-269.
33. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil and leukovorin as adjuvant treatment of colon cancer. N Engl J Med 2004; 350; 2343-2351.